Less than 10% (56/579) of the patients had non-adenocarcinomas (mostly squamous cell carcinomas), of whom only 5 had EGFR mutations (3.1% of all EGFR mutated patients) (Table 2). The gene discussed is EGFR; the disease is adenocarcinoma.